[ad_1] Teva Pharmaceutical Industries Ltd. obtained regulatory approval from the United States for the sale of a new migraine treatment, a key element of the company's recovery strategy. The stock has increased …
Read More »
[ad_1] Elon Musk's Boring Company continues to be validated by municipal authorities. In June, the company was chosen to build a multi-billion dollar fast transportation link between downtown Chicago and the international …
Read More »
[ad_1] Attorney General Zephyr Teachout on Wednesday made a request for support to rapper Cardi B. Professor Teachout, who chairs the New York Democratic primary on Thursday, congratulated Cardi a few minutes …
Read More »
[ad_1] Overall, only 36% approve of how the president manages his work, up from 42% in August. Among the self-employed, the decline was more marked, rising from 47% last month to 31%. …
Read More »
[ad_1] CVS Health President and CEO Larry J. Merlo. Reuters According to the Wall Street Journal, two massive mergers in the health sector will soon receive the go-ahead from the Justice Department. …
Read More »
[ad_1] Shares of Express Scripts Holding Co. surged Wednesday on a Wall Street Journal report that federal regulators are about to approve the $ 67 billion acquisition of the pharmaceutical benefits manager …
Read More »
[ad_1] WASHINGTON – Antitrust Authorities of Justice Department Prepare to Give Green Light to Two Major Agreements in Health Care Sector, CVS Health Body CVS 1.01% planned acquisition of a health insurer …
Read More »[ad_1] The EMA has approved Aimovig of Norvartis (erenumab), making it the first European treatment specifically designed to prevent migraine . The drug works by blocking the calcitonin gene. related peptide receptor …
Read More »
[ad_1] Last week, for the first time ever, the administration of food and drug approved a prescription drug based on marijuana components. Epidiolex contains a purified marijuana substance that does not produce …
Read More »
[ad_1] GW Pharmaceuticals plc GWPH a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics from its patented cannabinoid product platform, with its US subsidiary Greenwich Biosciences, announced on …
Read More »